Pasithea Therapeutics Corp. - Common Stock (KTTA)
2.2400
-0.0100 (-0.44%)
Pasithea Therapeutics Corp is a biotechnology company focused on the development of innovative therapies for the treatment of psychiatric and neurological disorders
The company is committed to leveraging advanced scientific research and cutting-edge technologies to create new treatment options that address unmet medical needs in these challenging areas. Pasithea aims to improve the quality of life for patients suffering from conditions such as depression and anxiety by exploring novel approaches in drug discovery and development. Through its work, Pasithea seeks to make a meaningful impact on mental health care and enhance overall well-being in affected individuals.
Frequently Asked Questions
Is Pasithea Therapeutics Corp. - Common Stock publicly traded?
Yes, Pasithea Therapeutics Corp. - Common Stock is publicly traded.
What exchange does Pasithea Therapeutics Corp. - Common Stock trade on?
Pasithea Therapeutics Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pasithea Therapeutics Corp. - Common Stock?
The ticker symbol for Pasithea Therapeutics Corp. - Common Stock is KTTA on the Nasdaq Stock Market
What is the current price of Pasithea Therapeutics Corp. - Common Stock?
The current price of Pasithea Therapeutics Corp. - Common Stock is 2.240
When was Pasithea Therapeutics Corp. - Common Stock last traded?
The last trade of Pasithea Therapeutics Corp. - Common Stock was at 3:59 pm EST on January 31st, 2025